Supplementary Table 2 from Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity
Eva Sum(Roche (Switzerland)), Pablo Umaña(Zurich Insurance Group (Switzerland)), Martin Lechmann(Roche (Switzerland)), Moritz Rapp(Center for Integrated Protein Science Munich), Thomas Emrich(Roche Pharma AG (Germany)), Whitney Jordaan(Roche (Switzerland)), Roberto Adelfio(Swiss Tropical and Public Health Institute), Anna Maria Giusti(University of Illinois Urbana-Champaign), Marine Le Clech(Roche (Switzerland)), Mario Perro(World Trade Organization), Ulrike Hopfer(Roche (Switzerland)), François Christen(Roche (Switzerland)), Dario Speziale(Roche (Switzerland)), Birte Appelt(Roche (Switzerland)), Anne Freimoser–Grundschober(Roche (Switzerland)), Andrzej Sobieniecki(Roche (Switzerland)), Philipp Fröbel(Roche (Switzerland)), Leo Kunz(Center for Pediatric Endocrinology Zurich), Felix Weber(Roche (Switzerland)), Valeria Nicolini(Roche (Switzerland)), Sara Labiano(Navarre Institute of Health Research), Peter Brünker(Roche (Switzerland)), Birgit Essig(Technical University of Munich), Christine Trumpfheller, Elena Menietti(Roche (Switzerland)), Pedro Romero(TiGenix (Spain)), Harald Dürr(Technical University of Munich)
Cited by 0
Related Papers
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
|Science|1996|1.3k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation
|Nature|2014|592
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
|PLoS Pathogens|2016|451
Metabolic and epigenetic regulation of T-cell exhaustion
|Nature Metabolism|2020|443